Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 9,127 shares at $3.75 ($34K) on 2016-04-12, disclosed to the SEC on 2016-04-13.
Open-market purchase of $34k LIFE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.70 | 6,546 | $24K | 71.4% |
| 2 | $3.75 | 2,581 | $10K | 28.6% |
| Total | $3.71 avg | 9,127 | $34K | 100% |
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |